GENEVA, Switzerland: The global epidemic innovations fund said on Tuesday it was working with a vaccine manufacturer to create a patch using mRNA technology, which would be easier to use against the coronavirus.
The Coalition for Epidemic Preparedness Innovations (CEPI) said it would provide up to $4.3 million to biotechnology company Vaxxas to advance development of a patch for mRNA vaccines.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.